Johnson & Johnson hit with $32M mesothelioma verdict in Los Angeles talc trial
A Los Angeles County Superior Court jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $32 million to the family of a California woman who died from pleural mesothelioma, concluding that her fatal cancer was directly caused by decades of exposure to asbestos-contaminated talc in the company's iconic baby powder.
The verdict concludes a multi-week trial centered on Maria Lozano, who passed away from the aggressive lung-lining cancer in 2024.
Following her death, the litigation was maintained by her surviving children, John Lozano, Araceli Lenard-Lozano, and Jeanette Lozano.
Throughout the proceedings in the litigation, Lozano v. Johnson & Johnson, the family's legal team from Dean Omar Branham Shirley (DOBS) presented internal corporate records and expert testimony demonstrating that Ms. Lozano applied Johnson’s Baby Powder routinely on herself and her children starting in the early 1970s.
The plaintiffs argued that J&J failed to warn the public about the severe risks associated with its cosmetic talc, despite possessing internal data for decades that highlighted sporadic asbestos contamination at its mining and processing sites.
Talc and asbestos are naturally occurring minerals that often form in close geographic proximity, creating a high risk of cross-contamination during extraction.
In its defense, the New Brunswick, New Jersey-based healthcare giant sought to distance its consumer products from the diagnosis.
J&J's legal counsel argued that Ms. Lozano's asbestos exposure originated from alternative environmental and occupational factors.
Specifically, the defense pointed to environmental conditions in Mexico City, where she resided for the first 21 years of her life, her history with independent cosmetic brands, and residual dust brought home from her husband’s automotive mechanical work.
The jury completely rejected the defense's alternative exposure arguments, assigning 0% liability to the Mexico City municipalities, external cosmetic brands, or automotive components.
Instead, the panel placed full institutional blame on Johnson & Johnson for manufacturing a defective product and failing to provide adequate safety labeling.
The $32 million award adds to a mounting multi-billion-dollar legal overhang for Johnson & Johnson, which abandoned its third attempt to resolve its talc liabilities through a prepackaged Chapter 11 bankruptcy restructuring in mid-2025.
Following that structural defeat, the company has been forced to litigate its remaining inventory of roughly 60,000 talc-related claims individually across various state jurisdictions, resulting in highly volatile courtroom outcomes ranging from outright defense victories to massive punitive damages awards.
